Structural requirements for G(o) activation by receptor-derived peptides: Activation and modulation domains of the α2-adrenergic receptor i3c region

Molecular Pharmacology

Volumn 50, Issue 2, 1996, Pages 351-358

  Wade, Susan M ^a   Scribner, Mary K ^a   Dalman, Hiroko Mori ^a,b   Taylor, Joan M ^a,c   Neubig, Richard R ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MASTOPARAN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G0 PHASE; CONFORMATIONAL TRANSITION; ENZYME INHIBITION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; CRICETINAE; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; RECEPTORS, ADRENERGIC, ALPHA-2; STRUCTURE-ACTIVITY RELATIONSHIP; VIRULENCE FACTORS, BORDETELLA;

EID: 0029841941     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Hepler, J. R., and A. G. Gilman. G proteins. Trends Biochem. Sci. 17: 383-387 (1992).
2. Brown, A. M., and L. Birnbaumer. Ionic channels and their regulation by G protein subunits. Annu. Rev. Physiol. 52:197-213 (1990).
3. Lefkowitz, R. J., and M. G. Caron. Adrenergic receptors: models for the study of receptors coupled to guanine nucleotide regulatory proteins. J Biol. Chem. 263:4993-4996 (1988).
4. Schimerlik, M. I. Structure and regulation of muscarinic receptors. Annu. Rev. Physiol. 51:217-227 (1989).
5. Strader, C. D., I. S. Sigal, and R. A. F. Dixon. Structural basis of β-adrenergic receptor function. FASEB J. 3:1825-1832 (1989).
6. 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science (Washington D. C.) 240:1310-1316 (1988).
7. Hamm, H. E., D. Deretic, A. Arendt, P. A. Hargrave, B. Koenig, and K. P. Hofmann. Site of G protein binding to rhodopsin mapped with synthetic peptides from the α subunit. Science (Washington D. C.) 241:832-835 (1988).
8. König, B., A. Arendt, J. H. McDowel, M. Kahlert, P. A. Hargrave, and K. P. Hofmann. Three cytoplasmic loops of rhodopsin interact with transducin. Proc. Natl. Acad. Sci. USA 86:6878-6882 (1989).
9. Hargrave, P. A., H. E. Hamm, and K. P. Hofmann. Interaction of rhodopsin with the G-protein, transducin. Bioessays 15:43-50 (1993).
10. Taylor, J. M., and R. R. Neubig. Peptides as probes for G protein signal transduction. Cell. Signal. 6:841-849 (1994).
11. Munch, G., C. Dees, M. Hekman, and D. Palm. Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide binding regulatory protein: structural and functional studies by β-receptor-site-specific peptides. Eur. J. Biochem. 198:357-364 (1991).
12. 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. J. Biol. Chem. 266:11025-11029 (1991).
13. Ikezu, T., T. Okamoto, E. Ogata, and I. Nishimoto. Amino acids 356-372 constitute a Gi-activator sequence of the α2-adrenergic receptor and have a Phe substitute in the G protein-activator sequence motif. FEBS Lett. 311:29-32 (1992).
14. 2A-adrenergic receptor peptides on G proteins. FASEB J. 5:A1594 (1991).
15. 2b-adrenergic, muscarinic (M4) and opiate (δ) receptors in NG108-15 membranes. FASEB J. 5:A1594 (1991).
16. 2 receptor are involved in functional G protein-mediated coupling to adenylyl cyclase. FEBS Lett. 325:215-219 (1993).
17. Plutner, H., R. Schwaninger, S. Pind, and W. E. Balch. Synthetic peptides of the Rab effector domain inhibit vesicular transport through the secretory pathway. EMBO J. 9:2375-2383 (1990).
18. Higashijima, T., J. Burnier, and E. M. Ross. Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines: mechanism and structural determinants of activity. J. Biol. Chem. 265:14176-14186 (1990).
19. 2-adrenergic receptor. FEBS Lett. 365:13-17 (1995).
20. 1A receptor synthetic peptides: mechanisms of adenylyl cyclase inhibition. J. Biol. Chem. 269:16720-16725 (1994).
21. 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267:8342-8346 (1992).
22. Voss, T., E. Wallner, A. P. Czernilofsky, and M. Freissmuth. Amphipathic α-helical structure does not predict the ability of receptor-derived synthetic peptides to interact with guanine nucleotide-binding regulatory proteins. J. Biol. Chem. 268:4637-4642 (1993).
23. Mukai, H., E. Munekata, and T. Higashijima. G protein antagonists: a novel hydrophobic peptide competes with receptor for G protein binding. J. Biol. Chem. 267:16237-16243 (1992).
24. 2adrenergic receptor third intracellular loop peptide to Gβ and the amino-terminus of Gα. J Biol. Chem. 269:27618-27624 (1994).
25. Taylor, J. M., M. VanDort, G. Jacob-Mosier, R. G. Lawton, and R. R. Neubig. Receptor and membrane interaction sites on Gβ: a receptor-derived peptide binds to the carboxy-terminus. J. Biol. Chem. 271:3336-3339 (1996).
26. 2-adrenergic receptor. J. Biol. Chem. 265:17307-17317 (1990).
27. Wade, S. M., H. M. Dalman, S. Yang, and R. R. Neubig. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function. Mol. Pharmacol. 45:1191-1197 (1994).
28. Hiratsuka, T. New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes. Biochim. Biophys. Acta 742:496-508 (1983).
29. Remmers, A. E., R. Posner, and R. R. Neubig. Fluorescent guanine nucleotide analogs and G protein activation. J. Biol. Chem. 269:13771-13778 (1994).
30. 2 adrenergic agonist binding with guanine nucleotide regulatory proteins. Biochemistry 26:3664-3672 (1987).
31. 2-adrenergic receptors in purified membranes from human platelets: implications of receptor-inhibitory nucleotide binding protein stoichiometry. Mol. Pharmacol. 28:475-486 (1985).
32. Huang, R., C., R. N. DeHaven, A. H. Cheung, R. E. Diehl, R. A. F. Dixon, and C. D. Strader. Identification of allosteric antagonists of receptor-guanine nucleotide-binding protein interactions. Mol. Pharmacol. 37:304-310 (1990).
33. Higashijima, T., S. Uzu, T. Nakajima, and E. M. Ross. Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J. Biol. Chem. 263:6491-6494 (1988).
34. Weingarten, R., L. Ransnas, H. Mueller, L. A. Sklar, and G. M. Bokoch. Mastoparan interacts with the carboxyl terminus of the α subunit of Gi. J. Biol. Chem. 265:11044-11049 (1990).
35. 125I-Tyr3,Cys11]mastoparan to Go. J. Biol. Chem. 266:12655-12661 (1991).
36. 1 subtypes couple to a single effector mechanism. Mol. Pharmacol. 40:707-711 (1991).
37. i3. University of Michigan, Ann Arbor, MI (1992).
38. Borders, J. A., Jr., Broadwater, P. A. Bekeny, J. E. Salmon, A. S. Lee, A. M. Eldridge, and V. B. Pett. A structural role for arginine in proteins: multiple hydrogen bonds to backbone carbonyl oxygens. Protein Sci. 3:541-548 (1994).
39. Shinagawa, K., M. Ohya, T. Higashijima, and K. Wakamatsu. Circular dichroism studies of the interaction between synthetic peptides corresponding to intracellular loops of β-adrenergic receptors and phospholipid vesicles. J. Biochem. (Tokyo) 115:463-468 (1994).
40. Wade, S. M., H. M. Dalman, S. Yang, and R. R. Neubig. Enhanced potency of dimeric peptides in modifying G protein function. FASEB J. 8(4): A354 (1994).
41. Ren, Q., H. Kurose, R. J. Lefkowitz, and S. Cotecchia. Constitutively active mutants of the α2-adrenergic receptor. J. Biol. Chem. 268:16483-16487 (1993).
42. West, R. E., Jr., J. Moss, M. Vaughan, T. Liu, and T. Y. Liu. Pertussis toxin-catalyzed ADP-ribosylation of transducin: cysteine 347 is the ADP-ribose acceptor site. J. Biol. Chem. 260:14428-14430 (1985).
43. 1γ22. Cell 83:1047-1058 (1995).
44. Lambright, D. G., J. Sondek, A. Bohm, N. P. Skiba, H. E. Hamm, and P. B. Sigler. The 2.0 A crystal structure of a heterotrimeric G protein. Nature (Lond.) 379:311-319 (1996).
45. Moro, O., J. Lameh, P. Hogger, and W. Sadee. Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J. Biol. Chem. 268:22273-22276 (1993).
46. Borjigin, J., and J. Nathans. Insertional mutagenesis as a probe of rhodopsin's topography, stability, and activity. J. Biol. Chem. 269:14715-14722 (1994).
47. Ohyama, K., Y. Yamano, S. Chaki, T. Kondo, and T. Inagami. Domains for G protein coupling in angiotensin II receptor type I: studies by site-directed mutagenesis. Biochem. Biophys. Res. Commun. 189:677-683 (1992).
48. s in response to muscarinic agonists. J. Biol. Chem. 265:6219-6224 (1990).
49. Palm, D., G. Munch, C. Dees, and M. Hekman. Mapping of β-adrenoceptor coupling domains to Gs-protein by site- specific synthetic peptides. FEBS Lett. 254:89-93 (1989).
50. Burstein, E. S., T. A Spalding, D. Hill-Eubanks, and M. R. Brann. Structure-function of muscarinic receptor coupling to G proteins: random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins. J. Biol. Chem. 270:3141-3146 (1995).
51. Van Koppen, C. J., A. Sell, W. Lenz, and K. H. Jakobs. Deletion analysis of the m4 muscarinic acetylcholine receptor: molecular determinants for activation of but not coupling to the Gi guanine-nucleotide-binding regulatory protein regulate receptor internalization. Eur. J. Biochem. 222:525-531 (1994).
52. Bylund, D. B., and M. L. Toews. Radioligand binding methods: practical guides and tips. Am. J. Physiol. 265:L421-L429 (1993).
53. s. Mol. Pharmacol. 41:1061-1065 (1992).
54. Pei, G., P. Samama, M. Lohse, M. Wang, J. Codina, and R. J. Lefkowitz. A constitutively active mutant β2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc. Natl, Acad. Sci. USA 91:2699-2702 (1994).
55. Ren, Q., H. Kurose, R. J. Lefkowitz, and S. Cotecchia. Constitutively active mutants of the α2-adrenergic receptor [Erratum appears in J. Biol. Chem. 269:1566 (1994)]. J. Biol. Chem. 268:16483-16487 (1993).
56. Kjelsberg, M. A., S. Cotecchia, J. Ostrowski, M. G. Caron, and R. J. Lefkowitz. Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site: evidence for a region which constrains receptor activation. J. Biol. Chem. 267:1430-1433 (1992).
57. Laue, L., W. Y. Chan, A. J. W. Hsueh, M. Kudo, S. Y. Hsu, S. M. Wu, L. Blomberg, and G. B. Cutler, Jr. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor gene in familial male-limited precocious puberty. Proc. Natl. Acad. Sci. USA 92: 1906-1910 (1994).
58. Parma, J., L. Duprez, J. Van Sande, P. Cochaux, C. Gervy, J. Mockel, J. Dumont, and G. Vassart. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (Lond.) 365:649-651 (1993).